Altamira Therapeutics Ltd. Adjustments For Increase Decrease In Trade Account Payable
Altamira Therapeutics Ltd. (CYTOF) reported Adjustments For Increase Decrease In Trade Account Payable of $30.99 thousand for the 6-month period ending 2024-06-30, per its 6-K filed 2024-09-24.
Discontinued › Notes
ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable · last filed 2024-09-24
CHF
| Period end | Adjustments For Increase Decrease In Trade Account Payable 6 month | Adjustments For Increase Decrease In Trade Account Payable 12 month |
|---|---|---|
| 2023-06-30 | -2.91M CHF 6-K · filed 2023-09-12 | |
| 2022-12-31 | 1.26M CHF 20-F · filed 2023-05-16 | |
| 2022-06-30 | -419.07K CHF 6-K · filed 2023-09-12 | |
| 2021-12-31 | 2.94M CHF 20-F · filed 2023-05-16 | |
| 2021-06-30 | 714.29K CHF 6-K/A · filed 2023-08-21 | |
| 2020-12-31 | -175.88K CHF 20-F · filed 2023-05-16 | |
| 2020-06-30 | 318.11K CHF 6-K · filed 2021-09-08 | |
| 2019-12-31 | -898.09K CHF 20-F · filed 2022-04-12 | |
| 2019-06-30 | -999.05K CHF 6-K/A · filed 2020-09-17 | |
| 2018-12-31 | 635.52K CHF 20-F · filed 2021-03-31 | |
| 2018-06-30 | 1.07M CHF 6-K · filed 2019-08-15 | |
| 2017-12-31 | -637.18K CHF 20-F · filed 2020-04-16 |
USD
| Period end | Adjustments For Increase Decrease In Trade Account Payable 6 month |
|---|---|
| 2024-06-30 | $30.99K 6-K · filed 2024-09-24 |
| 2023-06-30 | -$3.19M 6-K · filed 2024-09-24 |